Diagnostic immunohistochemistry: what patients should know

Short answer
Diagnostic immunohistochemistry uses targeted stains on tissue to help pathologists identify cell types, clarify a diagnosis and guide appropriate next steps.
This answers one question. It is not a diagnosis and does not replace an assessment by a licensed doctor.
At a glance
- Sample
- Prepared tissue from a biopsy or operation
- Method
- Antibodies reveal selected proteins in cells
- Interpretation
- The overall pattern matters more than one marker alone
The short answer
The test is performed in a laboratory on a sample obtained during a biopsy or operation. Antibodies bind to selected proteins in the cells, producing a visible pattern that is assessed alongside the tissue's appearance under a microscope.
What the result can mean
A pathology report may describe a marker as positive, negative, focal or present with a particular intensity or location. These terms refer to staining in the submitted tissue; they are not a diagnosis by themselves. The pathologist combines the pattern with cell shape, tissue structure, clinical details and other test findings.
A panel of markers is often more informative than a single stain because different cell types can share proteins. The findings may help establish where abnormal cells originated, distinguish between conditions that look similar or identify a feature relevant to treatment selection. An unclear pattern can lead to additional stains, molecular testing or review of more tissue.
What to do after the report
Arrange a discussion with the clinician who requested the test and bring the full pathology report. Ask which markers were tested, how the combined pattern supports the stated diagnosis and whether any result affects treatment planning.
If the report says the sample was limited, indeterminate or needs correlation, confirm what will resolve the uncertainty. The next action might be review of existing slides, another laboratory method, imaging, a multidisciplinary discussion or collection of an additional sample. Do not interpret an isolated positive marker as proof of a particular cancer.
When to seek care
Immunohistochemistry itself is carried out on tissue outside the body, so concerns after sampling usually relate to the biopsy or operation. Contact the treating team promptly for increasing redness, warmth, swelling, discharge, fever, worsening pain or bleeding that does not settle with the instructions you were given. Seek urgent care for severe bleeding, fainting, marked breathing difficulty or rapidly worsening symptoms.
If you have received a report but no follow-up arrangement, contact the requesting clinic so the complete result can be explained in context and the next step is not delayed.
Questions for your doctor
Useful questions include: What diagnosis does the full staining pattern support? Were the controls and tissue sample adequate? Does the report identify the likely origin of the cells? Are further stains or molecular tests needed? Will these findings change my treatment choices or the timing of my next appointment?
Questions people ask
Does a positive immunohistochemistry marker confirm cancer?
Not by itself. Positive means that the tested protein was detected in the tissue. The marker's location and pattern must be interpreted with the microscopic appearance, clinical information and other findings.
Why might several immunohistochemistry stains be ordered?
Cells can share markers, so a panel helps the pathologist compare patterns and narrow the possible cell type or tissue of origin. Different markers may also answer separate diagnostic or treatment-related questions.
Can immunohistochemistry need to be repeated?
Repeat or additional testing may be needed when tissue is limited, a control is unsatisfactory, the pattern is inconclusive or a new clinical question requires another marker.
Related
Related reading
Keep reading
Cancer care in the UAE
Hospitals & Medical Centers in Abu Dhabi
Most UAE cancer care is delivered inside hospital services rather than by standalone oncology clinics, so these are licensed hospitals & medical centers listed in Abu Dhabi. Confirm the specific cancer service exists before you travel, and know that asking for a second opinion is routine.
Ahalia Hospital Musaffah Building - Musaffah - Musaffah Industrial - Abu Dhabi - United Arab Emirates
Accepts: Daman, Thiqa, AXA, Cigna +26 more
Al Ruwais Industrial City - Abu Dhabi - United Arab Emirates
Accepts: Daman, Thiqa, AXA, Cigna +30 more
Abu Dhabi, Abu Dhabi
Accepts: Daman, Thiqa, AXA, Cigna +30 more
Second opinions are routine in cancer care and asking for one does not affect your treatment. How to arrange a second opinion in the UAE.
Ordered by verification status and how complete each clinic's public record is, then alphabetically. This is a directory listing, not a ranking — Zavis does not rate or recommend providers.
A factual listing drawn from the DHA, DOH and MOHAP licence registers. It is not a referral, an endorsement, or advice that any of these providers is right for you.
Medical disclaimer. This page is general health information, not medical advice, and it cannot diagnose you. Always consult a licensed healthcare provider about your own symptoms and treatment. In an emergency in the UAE, call 998 for an ambulance.